Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research team develops cancer-curing T-lymphocyte-based therapy to eradicate malignant tumours

20.10.2005


In a major research initiative funded by The Terry Fox Foundation, Claude Perreault, Canada Chair in Immunobiology at the Institute of Research in Immunology and Cancer (IRIC) of the Université de Montréal, has succeeded in developing a new approach to eradicate malignant melanoma tumours in mice. The findings of Dr. Perreault and his research team are reported in an article just published in the online edition of Nature Medicine, and soon to be published in the print edition of the publication.

In brief, the method developed by Perreault consists of administering T-lymphocytes – cells whose function it is to recognize and destroy abnormal cells – from a healthy mouse donor to mice with cancer. These lymphocytes are pre-immunized against a specific antigen (H7a) present in host mouse cancer cells. Although the target antigen is found in some of the host’s healthy cells, the treatment does not cause any side effects because the anti-H7a lymphocytes cluster almost exclusively around the tumour site where they are attracted to the molecule VCAM-1 present on the blood vessels that irrigate the tumour. The T-lymphocytes produce interferon gamma and perforine/granzyme to eradicate cancerous cells.

"We are very pleased with the insights yielded to date from this research project which our team initiated in 2003, explains Dr. Perreault. Thanks to another five-year grant from the Canadian Cancer Society, we have moved on directly to explore the cancer-curing potential of this immunotherapeutic method in the treatment of human melanoma. We may be only a few years away from testing the application on human beings. The prospect of this work leading to the development of an effective, nontoxic and non-invasive therapy against certain types of cancer for broad clinical use is exciting for every basic research students, scientist and doctors working on this project."

"Malignant melanoma is a devastating disease, affecting 4,300 Canadians this year and leading to 880 deaths. In fact, melanoma rates are increasing for both women and men," said Dr. Michael Wosnick, executive director of the National Cancer Institute of Canada, the research arm of the Canadian Cancer Society and The Terry Fox Foundation. "For these reasons, these results are promising and if proven successful in human clinical trials, this therapy could have a tremendous impact on the treatment of this disease."

About the Institute for Research in Immunology and Cancer (IRIC)

IRIC is an internationally-competitive systems biology research centre dedicated to cancer research. It is led by a group of elite scientists from Canada, Europe and the United States and engages in ambitious cross-disciplinary collaborations to tackle some of the greatest obstacles to human health we are faced with today. IRIC opened its doors at the heart of the University de Montréal campus in spring 2005 and is expected to double in size over the coming years, bringing together some 40 research teams -- for a total of some 500 scientists, postdoctoral trainees, graduate students, professionals and administrative staff -- by 2008.

About the National Cancer Institute of Canada

Funded by the Canadian Cancer Society and The Terry Fox Foundation, the National Cancer Institute of Canada is the longest-standing and most prestigious Canadian research organization devoted to advancing cancer control. This year, the Institute is providing $63 million to support excellent cancer research and related programs across the country.

About Université de Montréal

Founded in 1878, the Université de Montréal, with its two affiliated schools, the École Polytechnique and the HEC Montréal, is now the largest university in Quebec and the second largest in Canada. With over 55,000 students from around the world and some 10,000 employees, the Université de Montréal awards close to 10,000 diplomas at every university level. Deeply rooted in Montreal and dedicated to its international mission, the Université de Montréal is one of the top universities in the Frenchspeaking world.

| EurekAlert!
Further information:
http://www.umontreal.ca

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>